Literature DB >> 19898971

Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues.

James E Carter1, Oludare Odumosu, William H R Langridge.   

Abstract

Onset of juvenile Type 1 diabetes (T1D) occurs when autoreactive lymphocytes progressively destroy the insulin-producing beta-cells in the pancreatic Islets of Langerhans. The increasing lack of insulin and subsequent onset of hyperglycemia results in increased damage to nerves, blood vessels, and tissues leading to the development of a host of severe disease symptoms resulting in premature morbidity and mortality. To enhance restoration of normoglycemia and immunological homeostasis generated by lymphocytes that mediate the suppression of autoimmunity, the non-toxic B chain of the plant AB enterotoxin ricin (RTB), a castor bean lectin binding a variety of epidermal cell receptors, was genetically linked to the coding region of the proinsulin gene (INS) and expressed as a fusion protein (INS-RTB) in transformed potato plants. This study is the first documented example of a plant enterotoxin B subunit linked to an autoantigen and expressed in transgenic plants for enhanced immunological suppression of T1D autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19898971      PMCID: PMC3565754          DOI: 10.1007/s12033-009-9217-1

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  48 in total

1.  Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.

Authors:  C Aspord; C Thivolet
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

2.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.

Authors:  Dora Li; Jennifer O'Leary; Yan Huang; Norman P A Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2005-12-02       Impact factor: 4.570

3.  Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.

Authors:  M Polanski; N S Melican; J Zhang; H L Weiner
Journal:  J Autoimmun       Date:  1997-08       Impact factor: 7.094

4.  Expression of functional hexahistidine-tagged ricin B in tobacco.

Authors:  Deborah G Reed; Luis H Nopo-Olazabal; Vanessa Funk; Bonnie J Woffenden; Michael J Reidy; Maureen C Dolan; Carole L Cramer; Fabricio Medina-Bolivar
Journal:  Plant Cell Rep       Date:  2004-12-15       Impact factor: 4.570

5.  Purification of ricin A1, A2, and B chains and characterization of their toxicity.

Authors:  R J Fulton; D C Blakey; P P Knowles; J W Uhr; P E Thorpe; E S Vitetta
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

6.  Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

Authors:  R Maron; N S Melican; H L Weiner
Journal:  J Autoimmun       Date:  1999-06       Impact factor: 7.094

7.  Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.

Authors:  R Maron; M Guerau-de-Arellano; X Zhang; H L Weiner
Journal:  J Autoimmun       Date:  2001-02       Impact factor: 7.094

8.  Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato.

Authors:  Nak-Won Choi; Mary K Estes; William H R Langridge
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

9.  Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice.

Authors:  Nak-Won Choi; Mary K Estes; William H R Langridge
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

Review 10.  Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.

Authors:  Doreen Manuela Floss; Dieter Falkenburg; Udo Conrad
Journal:  Transgenic Res       Date:  2007-04-14       Impact factor: 2.788

View more
  7 in total

1.  Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies.

Authors:  Ankit Singh; Subhi Srivastava; Ankita Chouksey; Bhupendra Singh Panwar; Praveen C Verma; Sribash Roy; Pradhyumna K Singh; Gauri Saxena; Rakesh Tuli
Journal:  Mol Biotechnol       Date:  2015-04       Impact factor: 2.695

Review 2.  Current advances and future prospects in production of recombinant insulin and other proteins to treat diabetes mellitus.

Authors:  Sapna Bhoria; Jyoti Yadav; Honey Yadav; Darshna Chaudhary; Ranjana Jaiwal; Pawan K Jaiwal
Journal:  Biotechnol Lett       Date:  2022-04-17       Impact factor: 2.461

3.  Production of pharmaceutical proteins in solanaceae food crops.

Authors:  Maria Manuela Rigano; Giorgio De Guzman; Amanda M Walmsley; Luigi Frusciante; Amalia Barone
Journal:  Int J Mol Sci       Date:  2013-01-29       Impact factor: 5.923

Review 4.  AB toxins: a paradigm switch from deadly to desirable.

Authors:  Oludare Odumosu; Dequina Nicholas; Hiroshi Yano; William Langridge
Journal:  Toxins (Basel)       Date:  2010-06-25       Impact factor: 4.546

Review 5.  The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.

Authors:  Maria A Souza; Fernanda C Carvalho; Luciana P Ruas; Rafael Ricci-Azevedo; Maria Cristina Roque-Barreira
Journal:  Glycoconj J       Date:  2013-01-09       Impact factor: 2.916

Review 6.  Plant Platforms for Efficient Heterologous Protein Production.

Authors:  Siddhesh B Ghag; Vinayak S Adki; Thumballi R Ganapathi; Vishwas A Bapat
Journal:  Biotechnol Bioprocess Eng       Date:  2021-08-07       Impact factor: 2.836

7.  Expression and Immunogenicity of M2e Peptide of Avian Influenza Virus H5N1 Fused to Ricin Toxin B Chain Produced in Duckweed Plants.

Authors:  Aleksey Firsov; Irina Tarasenko; Tatiana Mitiouchkina; Lyubov Shaloiko; Oleg Kozlov; Leonid Vinokurov; Ekaterina Rasskazova; Arkadii Murashev; Alexander Vainstein; Sergey Dolgov
Journal:  Front Chem       Date:  2018-02-13       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.